spacer
home > epc
PUBLICATIONS

European Pharmaceutical Contractor

 

Published quarterly, European Pharmaceutical Contractor (EPC) covers the essential contract research issues between pharma companies and their CRO partners. The title, which is integrated within International Clinical Trials (ICT) magazine, offers a strategic view of the drug development industry – giving its pharma, biotech, and CRO readership expert insight and analysis on the sponsor-service provider landscape.

EPC focusses on key trends, concerns, and developments in contract research operations across the drug development spectrum, from preclinical to post-marketing. It explores the shifting collaborative needs and practical implications for sponsors and their contract partners, with the emphasis on building and managing effective collaborations.

Prompted by the synergies between outsourcing and trial operations, EPC joined forces with sister brand ICT in late-2015, in a move that brings added value to both brands. With EPC now an inserted edition within ICT, industry practitioners across these complementary subject areas now have unrivalled access to a wealth of shared views and analyses.

For further information please contact:

Advertising
George Briggs

Editorial
Joel Emmons

We're also on Twitter! Follow us @EPCmagazine


Click here to view the digital
version of EPC


 

 Read our publications on the go in the Samedan app for phones and tablets. You can download issues for offline reading, and our archives go as far back as 2008! Download for free on the App Store, GooglePlay, or Amazon.

 
epc
 
 
Featured in this issue
Clinical data
From EDC to eSource

Overcoming the Industry's Data Crisis

With an industry-wide aim for improved data collection, Ed Seguine at Clinical Ink discusses the current view that pharma is locked in an innovation paradox.
Clinical data
Clinical Trial Sponsors

Preparations for the New EU Portal

Thomas Wicks at Trialscope explores the ways in which clinical trials in the EU will be forced to change when new regulations come into play, and how organisations should prepare for these changes.
  Clinical data
Real-World Evidence in Drug Development

Fit for Purpose

IQVIA Biotech’s Marni Hall and Nicola Stanislaus evaluate the framework of real-world evidence application in clinical trials and the coordinated efforts of pharmaceutical companies and regulatory bodies.

spacer



Published quarterly in
February, May,
August, and November


 

Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 
News and Press Releases

Signant Health Appoints Lawrence Miller as Chief Technology Officer

LONDON & PHILADELPHIA – June 13, 2019: Signant Health, formerly CRF Bracket, has appointed Lawrence Miller as Chief Technology Officer. Signant unites electronic Clinical Outcomes Assessment (eCOA), eConsent, Patient Engagement, Interactive Response Technology (IRT), Clinical Supply Management and Endpoint Quality into the industry’s most comprehensive patient-centric suite of technology solutions and services. An accomplished innovator, Miller brings unique vision and expertise to a Signant team already committed to advancing clinical research with its next-generation technology portfolio.
More info >>

air transport logo

 

White Papers

Competitive Drive: The Challenges of a Globalised Packaging Industry

Aesica Pharmaceuticals

Packaging is becoming an increasingly competitive and lucrative industry globally. Jeremy Drummond PhD of Aesica Formulated Products looks at the challenges and opportunities this presents.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement